FUCORAN
LIVE

Serial Number

79394803

Owner

JANG, BONG KEUN

Attorney

James C. Watson

Filing Date

Mar 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

FUCORAN Trademark

Serial Number: 79394803 • Registration: 8081506

FUCORAN is a trademark filed by JANG, BONG KEUN on March 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

JANG, BONG KEUN (4 trademarks)

#201-2105, 10, Giheungyeok-ro 58beon-gil,

Entity Type: 01

Trademark Details

Filing Date

March 12, 2024

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Nutraceutical preparations in the nature of dietary supplements containing sea tangle in the form of capsules or powders; nutraceutical preparations in the nature of dietary supplements containing sea tangle extracts; food supplements; nutraceuticals for use as a dietary supplement; nutraceuticals for therapeutic purposes specifically for the treatment of cancer, diabetes, and viral, metabolic, cardiovascular, gastrointestinal, and immune system related diseases and disorders; nutraceutical preparations in the form of capsules or powders in the nature of nutraceuticals for use as a dietary supplement; nutraceutical preparations in the nature of dietary supplements containing algae in the form of capsules or powders; nutraceutical preparations in the nature of dietary supplements containing fucoidan, alginic acid, and laminarin in the form of capsules or powders; nutraceutical preparations in the nature of dietary supplements containing fucoidan in the form of capsules or powders; pharmaceutical preparations for the treatment of cancer, diabetes, and viral, metabolic, cardiovascular, gastrointestinal, and immune system related diseases and disorders for use in the health care industry; dietary supplements; dietary and nutritionally fortified food products adapted for medical purposes in the nature of dietetic foods adapted for medical use; medicated food supplements in the nature of dietetic foods adapted for medical use; pharmaceutical drugs in the nature of pharmaceutical preparations for the treatment of cancer, diabetes, and viral, metabolic, cardiovascular, gastrointestinal, and immune system related diseases; medicines for the treatment of cancer, diabetes, and viral, metabolic, cardiovascular, gastrointestinal, and immune system related diseases for human purposes; plant extracts, other than essential oils, for medical and pharmaceutical purposes; nutraceutical preparations for therapeutic or medical purposes specifically for the treatment of cancer, diabetes, and viral, metabolic, cardiovascular, gastrointestinal, and immune system related diseases and disorders.

Filing History

TEAS SECTION 7 REQUEST RECEIVED
Apr 17, 2026 ES7R
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 18, 2025 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 13, 2025 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 2, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 4, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 4, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 13, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 13, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 2, 2024 REPR